ARTICLE | Company News
GSK to sell "non-core" OTC products
April 16, 2011 12:43 AM UTC
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it plans to sell a portfolio of "non-core" OTC products that had combined sales of about L500 million ($817.4 million) in 2010. GSK believes other companie...